Watchlist, Economic Calender, Upgrades Downgrades, Gap Stocks, Day Trading

posted by:  elvis                     date:  5/4/2011

May 4, 2011
New orders may be slowing but not growth in backlogs or inventories. ISM will post April data on non-manufacturing.


Watchlist:  EMR ADM XOP SU LRCX FMCN CHK MRO WLL ACI FTI AMX SLW AEM CELG ACN BEXP LVS RIMM
----------------

Notable earnings before Wednesday's open: AGNAGUAOL,DVNGRMNKKKRMGMMMCNXPIPCGPWRRRDTLMTRWTWX
Notable earnings after Wednesday's close: ACEARIAATML,BMCBMRCLDCLWRCXOERTSETPEXPDGGGLBL, IOJDSUKIM,LBTYALEAPMETMTZMURNWSAONNNPRURIGTSLATSO,WFMIWFRWINWMB

Eric Rosengren Speaks8:00 AM ET
ADP Employment Report
[djStar]8:15 AM ET
ISM Non-Mfg Index
[Report][djStar]
10:00 AM ET
John Williams Speaks3:00 PM ETDennis Lockhart Speaks7:00 PM ET
----------------
Up/Downgrades (BLK, BEAT, CEDC, DKS, FEIC, GKSR, RDC, VCLK, AMAG, AMX, STD, CCC, CHK, DGI, KAR, LM, NSC, SMG, VRX, VLCM)

Upgrades
BlackRock (NYSE:BLK), the alternative asset manager, was upgraded to a Buy from Neutral at Ticonderoga. The firm set its target price at $225, noting the company is leveraged to growing asset classes, is likely past the bulk of merger outflows, and will likely continue to grow payout ratios for shareholders over time in the form of dividends and buybacks, probably through repurchases from owners rather than in the open market.
CardioNet (NASDAQ:BEAT) was upgraded to a Hold from Sell at Citigroup.
Central European Distribution (NASDAQ:CEDC) was downgraded to a Neutral from Buy at Goldman Sachs.
Dick's Sporting Goods (NYSE:DKS), the sporting goods retailer, was upgraded to Outperform from Perform at Oppenheimer. The firm set its target price at $50 saying sales and EPS trends have improved significantly in the past several quarters as discretionary spending has recovered.
FEI Company (NASDAQ:FEIC) was upgraded to a Buy from Neutral at Merriman.
G&K Services (NASDAQ:GKSR) was upgraded to a Neutral from Underweight at JP Morgan.
Rowan Companies (NYSE:RDC) was upgraded to a Strong Buy from Sell at Duncan-Williams. The firm set its target price at $54, as it believes the company has just reported the lowest quarter it should have for the next two years with increasing earnings quarter over quarter going forward.
ValueClick (NASDAQ:VCLK) was upgraded to a Buy from Neutral at Merriman. The company was also upgraded to a Buy from Hold at Needham, with the firm setting its target price at $25.
Downgrades
AMAG Pharmaceutical (NASDAQ:AMAG) was downgraded to a Neutral from Overweight at JP Morgan.
America Movil SA (NYSE:AMX) was downgraded to Market Perform from Outperform at Wells Fargo.
Banco Santander Central (NYSE:STD) was downgraded to Reduce from Neutral at WestLB.
Calgon Carbon (NYSE:CCC) was downgraded to Perform from Outperform at Oppenheimer. The firm believes the company's recent/near-term EPS growth performance does not warrant its growth multiple. Oppenheimer added that any benefit from recently introduced MACT regulations may not materialize until 2015, and there is a risk that competing technologies could usurp Activated Carbon's value proposition.
Chesapeake Energy (NYSE:CHK), the onshore natural gas and oil producer, was downgraded to Accumulate from Buy at Global Hunter following earnings results.
DigitalGlobe (NYSE:DGI) was downgraded to a Hold from Buy at The Benchmark Company. The firm lowered its target price to $30 from $38 following earnings and based on weaker FY11 commercial outlook.
KAR Auction Services (NYSE:KAR) was downgraded to a Neutral from Outperform at Robert W. Baird. The firm raised its target price to $21 from $18, noting the company reported a solid quarter, but states the limited upside supports its Neutral rating.
Legg Mason (NYSE:LM), the Baltimore, Maryland based global asset Management Company, was downgraded to Market Perform from Outperform at Keefe Bruyette.
Norfolk Southern (NYSE:NSC), the railroad operating primarily in the Southeast, East, and Midwest of the United States, was downgraded to a Hold from Buy at Jefferies.
Scotts Miracle-Gro (NYSE:SMG), the largest marketer of branded consumer lawn and garden products in the world, was downgraded to Sector Perform from Outperform at RBC Capital.
Vertex Pharmaceuticals (NYSE:VRX) was downgraded to a Hold from Buy at Brean Murray based on valuation. The firm is assigning a $53 fair value estimate to the stock. Vertex is poised to launch telaprevir, branded as INCIVEK, in the U.S. this quarter. The firm believes the initial launch will be robust given what is already a multibillion dollar market.
Volcom (NASDAQ:VLCM) was downgraded to a Hold from Buy at Jefferies - following PPR's pending acquisition.

----------------
Gainers, losers:
http://www.marketwatch.com/search?q=movers%20shakers

No comments :

Post a Comment